Acknowledgments
Sonia Ramos, PLM
ADVERSE EVENTS, MENDELSON
This trial was funded by the Bill & Melinda Gates Foundation (INV-017710), the South African Medical Research Council (96167), UK Research and Innovation (MC_PC_19055), and the UK National Institute for Health Research. PLM is supported by the South African Research Chairs Initiative of the Department of Science and Innovation and the NRF (grant 98341). The views expressed in this publication are those of the authors and not necessarily those of the funders. We thank all the volunteers who participated in this trial, the members of the data safety and monitoring committee (Robert Heyderman and Manish Sadarangani, co-chairs, Paul Kaye, Steve Black, George Bouliotis, Gregory Hussey, Bernhards Ogutu, Walter Orenstein, Sonia Ramos, Cornelia L Dekker, and Elizabeth Bukusi); and the local safety physician, Guy Richards, for reviewing all serious adverse events. We thank the independent case evaluation committee: Jeremy Carr, Steve Chambers, Kim Davis, Simon Drysdale, Charles Feldman, Malick Gibani, Elizabeth Hammershaimb, Michael Harrington, Celina Jin, Seilesh Kadambari, Rama Kandasamy, Carla Leisegang, Toby Maher, Jamilah Meghji, Marc Mendelson, Colin Menezes, Claire Munro, Jeremy Nel, David Pace, Rekha Rapaka, Robindra Basu Roy, Daniel Silman, and Jing Wang. We thank the following key trial team staff members for their valued contributions to the trial: Phindile Khumalo, Sibongile Jauza, Christinah Klaas, and Farisai Kuonza (Wits VIDA), Mrinmayee Dhar, Jean Le Roux, Tiffany Seef, and Sarah Jane Whitaker (Wits Reproductive Health and HIV Institute). We thank Bronwen Lambson, Zanele Makhado, and Donald Mhlanga for technical assistance.